{"result": {"id": "ab6426f9-0a7d-4992-8e31-64f54da28d59", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>尼群地平<|>ORGANIZATION<|>Nitrendipine, a calcium channel blocker used in antihypertensive treatment\")  \n##  \n(\"entity\"<|>硝苯地平<|>ORGANIZATION<|>Nifedipine, a calcium channel blocker used in hypertension management\")  \n##  \n(\"entity\"<|>噻嗪类利尿剂<|>ORGANIZATION<|>Thiazide diuretics, a class of traditional antihypertensive drugs\")  \n##  \n(\"entity\"<|>β受体阻滞剂<|>ORGANIZATION<|>Beta-blockers, a class of traditional antihypertensive medications\")  \n##  \n(\"relationship\"<|>尼群地平<|>Syst-China<|>Nitrendipine was used as a key drug in the Syst-China trial<|>8)  \n##  \n(\"relationship\"<|>硝苯地平<|>Syst-China<|>Nifedipine was used in the Syst-China trial for hypertension treatment<|>7)  \n##  \n(\"relationship\"<|>噻嗪类利尿剂<|>SPRINT<|>Thiazide diuretics were likely used in the SPRINT trial among other antihypertensives<|>5)  \n##  \n(\"relationship\"<|>β受体阻滞剂<|>SPRINT<|>Beta-blockers may have been used in the SPRINT trial as part of combination therapy<|>5)  \n##  \n(\"relationship\"<|>CCB<|>ACEI<|>Both are classes of antihypertensive drugs frequently compared in clinical trials<|>6)  \n##  \n(\"relationship\"<|>CCB<|>ARB<|>Both are modern antihypertensive drug classes often studied against traditional therapies<|>6)  \n##  \n(\"relationship\"<|>ACEI<|>ARB<|>Both target the renin-angiotensin system and are compared in hypertension treatment<|>7)  \n##  \n(\"relationship\"<|>STEP<|>Syst-China<|>Both are Chinese clinical trials investigating antihypertensive strategies<|>5)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558631, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 478, "prompt_tokens": 3036, "total_tokens": 3514, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2624}, "prompt_cache_hit_tokens": 2624, "prompt_cache_miss_tokens": 412}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 疗与安慰剂或不治疗 ,结果 显示降压治疗可以显著降低各种类型的高血压患者发 生心脑血管并发症的风险 。这些研究是治疗与管理各 种类型的高血压最重要的理论基础[214-215] 。\n　　　(2) 不同种类的药物之间进行对比的临床试验。 主要对比研究较新的降压药如钙通道阻滞药(calcium  channelblocker,CCB) 、血管紧张素转换酶抑制药(an- giotensin-converting enzyme inhibitors, ACEI) 、血管  紧张素 受 体 阻 滞 药 (angiotensin receptor blockers,  ARB)等与传统的降压药如噻嗪类利尿剂、β受体阻滞  剂等 ,结果显示降低血压是这些降压药减少心脑血管  并发症的最主要原因[216] 。药物之间的差别总体很  小 ,但在特定人群中或对特定并发症而言仍有差别 ,不  同联合治疗方案也有差异[217] 。\n　　　(3)选择高血压患者作为研究对象的研究 。通过  对比强化与非强化的血压管理 ,寻找最佳降压治疗目  标血压 。在美国进行的 SPRINT入选高血压患者 ,进  行强化降压治疗临床试验 ,使用多种降压治疗药物 ,将  平均收缩压降低至 121mmHg,与降低至 133mmHg 相比 ,显著降低了复合心血管终点事件的发生率 ,主要  是心力衰竭[77,141] 。需要注意的是 ,SPRINT采用的自  动血压测量的数值明显低于(5~15mmHg) 以往临床  试验采用的常规诊室血压测量 。我国进行的老年高血  压患者血压干预策略(strategy of blood pressure in- tervention  in  the  elderly  hypertensive  patients,  STEP) 研究 , 采用相似的开放试验设计 , 选择 60~  79岁高血压患者人群 ,进一步证实了显著的血压差异  可以导致心血管事件的差异 ,主要是脑卒中[142] 。\n　　　(4)选择心血管风险高危或中危患者作为研究对 象的研究 。这些研究包括部分正常血压或血压已经得 到控制的患者 ,结果提示 ,在达到 140/90mmHg以下 的目标水平后 ,进一步降低血压应坚持个体化原则 ,应 充分考虑患者的疾病特征与降压治疗方案的组成及其 实施方法[137] 。\n　　　我国独立完成的降压治疗临床试验 :我国独立完 成了一系列降压治疗临床试验 ,并为多个国际多中心 临 床 试 验 做 出贡 献 。 较 早 进 行 的  Syst-China试 验[218-219] 以及上海老年高血压试验[220] 和成都市高血 压干预试验[221] 等均证实 , 以尼群地平、硝苯地平等 CCB为基础的积极降压治疗方案可显著降低我国高 血压 患 者 脑 卒 中 的 发 生\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CCB<|>ORGANIZATION<|>Calcium channel blocker, a type of antihypertensive drug used in the treatment of hypertension\")  \n##  \n(\"entity\"<|>ACEI<|>ORGANIZATION<|>Angiotensin-converting enzyme inhibitors, a class of antihypertensive drugs\")  \n##  \n(\"entity\"<|>ARB<|>ORGANIZATION<|>Angiotensin receptor blockers, a type of antihypertensive medication\")  \n##  \n(\"entity\"<|>SPRINT<|>EVENT<|>A clinical trial in the U.S. that studied intensive blood pressure lowering in hypertensive patients\")  \n##  \n(\"entity\"<|>STEP<|>EVENT<|>A Chinese study on blood pressure intervention strategies in elderly hypertensive patients\")  \n##  \n(\"entity\"<|>Syst-China<|>EVENT<|>A clinical trial in China testing antihypertensive treatment with calcium channel blockers\")  \n##  \n(\"entity\"<|>上海老年高血压试验<|>EVENT<|>Shanghai Elderly Hypertension Trial, a study on antihypertensive treatment in elderly patients\")  \n##  \n(\"entity\"<|>成都市高血压干预试验<|>EVENT<|>Chengdu Hypertension Intervention Trial, a study on hypertension management\")  \n##  \n(\"relationship\"<|>CCB<|>SPRINT<|>CCB drugs were used in the SPRINT trial for intensive blood pressure lowering<|>5)  \n##  \n(\"relationship\"<|>ACEI<|>SPRINT<|>ACEI drugs were likely used in the SPRINT trial among other antihypertensive medications<|>4)  \n##  \n(\"relationship\"<|>ARB<|>SPRINT<|>ARB drugs may have been used in the SPRINT trial as part of antihypertensive therapy<|>4)  \n##  \n(\"relationship\"<|>STEP<|>SPRINT<|>STEP study followed a similar design to SPRINT but focused on elderly Chinese patients<|>6)  \n##  \n(\"relationship\"<|>Syst-China<|>CCB<|>Syst-China trial used CCB drugs like nitrendipine and nifedipine for hypertension treatment<|>7)  \n##  \n(\"relationship\"<|>上海老年高血压试验<|>CCB<|>Shanghai Elderly Hypertension Trial involved CCB-based antihypertensive treatment<|>5)  \n##  \n(\"relationship\"<|>成都市高血压干预试验<|>CCB<|>Chengdu Hypertension Intervention Trial used CCB drugs in its treatment strategy<|>5)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_705d1b4b4cef71c4411bb64b3dce2fe374a40ec7566b09f15e197cbcfc053e2e_v2"}